Morpho-Immunohistochemical Characteristics of Different Mycosis Fungoides Stages: A Literature Review

AA Sherstnev, AM Kovrigina

PDF

KIR-Genetic Factors and Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

EV Kuzmich, IE Pavlova, LN Bubnova, SS Bessmeltsev

PDF

The Role of Autologous Hematopoietic Stem Cell Transplantation in the Therapy of Systemic AL Amyloidosis

OV Pirogova, OV Kudyasheva, AG Smirnova, VV Porunova, SV Tolstova, KR Kalimulina, MV Chernous, YuYu Vlasova, IS Moiseev, VA Dobronravov, AD Kulagin

PDF

T-Helper Subpopulations in Acute Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation

YuO Davydova, NM Kapranov, KA Nikiforova, OS Karavaeva, DV Kamelskikh, MYu Drokov, LA Kuzmina, TV Gaponova, IV Galtseva, EN Parovichnikova

PDF

Approaches to the Treatment of Patients with Myelofibrosis and Polycythemia Vera with Constitutional Symptoms in Real–World Clinical Practice in the Russian Federation: Intermediate Results of a Multi-Center Observational Prospective Clinical Study

AL Melikyan, IN Subortseva, SM Kulikov, YuA Chabaeva, EA Gilyazitdinova, KP Novoselov, EA Knyazeva, AS Egorova, IS Stepochkin, EV Koroleva, TM Sycheva, VP Belgesova, AYu Putintseva, OM Senderova, IV Vasil’eva, EYu Komartseva, AA Kaplina, VI Bakhtina, MA Mikhalev, YuB Chernykh, EN Parovichnikova

PDF

Quality of Life Changes in Patients with Chronic Immune Thrombocytopenia in the Process of Romiplostim Therapy, its Efficacy and Safety in the Real-World Setting: Results of a Multi-Center Observational Study

TI Ionova, OYu Vinogradova, TV Shelekhova, DG Sherstnev, AV Proidakov, EV Lyyurova, MM Pankrashkina, LA Mukha, EE Markova, NV Novitskaya, TI Pospelova, TN Babaeva, NB Bulieva, GB Kuchma, EA Andreevskaya, EE Zinina, MV Frolova, KB Trizna, IL Shestopalova, TV Shneider, SA Volkova, SG Zakharov, II Mulina, IE Solov’eva, AA Myasnikov, AA Kuchin, LB Khvorostenko, NM Porfirieva, TP Nikitina, VV Ptushkin, SV Gritsaev

PDF

Efficacy and Toxicity of Induction Therapy in Patients with Newly Diagnosed Systemic AL Amyloidosis: Results of a Prospective Single-Center Clinical Study

IG Rekhtina, VA Khyshova, MV Solov’ev, LP Mendeleeva

PDF

The Prognostic Value of Somatic Mutations of Epigenetic Regulation Genes in Acute Myeloid Leukemias in Real-World Clinical Practice: Results of an Observational Non-Interventional Prospective Interregional Study

AA Shatilova, IG Budaeva, AV Petukhov, SA Silonov, AE Ershova, TS Nikulina, YuD Matvienko, YuV Mirolyubova, KV Bogdanov, LV Anchukova, YuS Neredko, SYu Tyasko, OE Ochirova, AG Karpova, ER Vasil’eva, OD Serdyuk, DA Yaskulskii, DV Bukin, YuA Alekseeva, EG Lomaia, LL Girshova

PDF

Dynamics of SARS-CoV-2 RNA Detection in Patients and Employees of the National Research Center for Hematology During the First Two Years of the Novel COVID-19 Pandemic

OG Starkova, DS Tikhomirov, AYu Krylova, IO Snezhko, EN Ovchinnikova, OA Aleshina, TA Tupoleva, TV Gaponova

PDF

Long-Term Results of Classical Hodgkin’s Lymphoma Treatment in Real-World Clinical Practice: Experience of Novosibirsk Hematological Unit

MS Voitko, TI Pospelova, IN Nechunaeva, YaYu Shebunyaeva

PDF

Plasma Cell-Free DNA in Patients with Diffuse Large B-Cell and B-Cell High-Grade (Double Hit/Triple Hit) Lymphomas

SYu Smirnova, EE Nikulina, NG Gabeeva, DA Koroleva, SA Tatarnikova, AK Smol’yaninova, EG Gemdzhian, EE Zvonkov, AB Sudarikov

PDF

Ibrutinib Efficacy in First–Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

NV Kurkina, EA Repina, PV Volkova, AA Repin

PDF

The Prognostic Role of Genetic Aberrations in Mantle Cell Lymphoma: A Literature Review and Clinical Experience

EV Kleina, SV Voloshin, YuS Vokueva, OD Petukhova, EV Motyko, MP Bakai, DV Kustova, AN Kirienko, SYu Linnikov, EV Karyagina, OS Uspenskaya, IS Zyuzgin, SV Sidorkevich, IS Martynkevich

PDF

Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)

PDF